Showing results (51-60 of 386) with videos related to
Sort By:
Pageof 39
Drug Safety|December 12, 2001
Technologies to improve immunisation safetyC J Clements, M T Aguado, L JódarRheumatology (Oxford, England)|December 18, 2003
The health assessment questionnaire (HAQ) is strongly predictive of good outcome in early diffuse scleroderma: results from an analysis of two randomized controlled trials in early diffuse sclerodermaN Sultan, J E Pope, P J Clements, et al.Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|August 1, 1994
Glandular kallikrein gene expression in the human uterusJ Clements, A Mukhtar, A Ehrlich, et al.International Journal of Immunopharmacology|October 20, 1998
Delta9-tetrahydrocannabinol suppresses macrophage costimulation by decreasing heat-stable antigen expressionD J Clements, M Matveyeva, K L McCoyEuropean Journal of Gastroenterology & Hepatology|September 8, 2006
Cannabis use improves retention and virological outcomes in patients treated for hepatitis CDiana L Sylvestre, Barry J Clements, Yvonne MalibuCurrent Rheumatology Reports|May 16, 2007
Management of interstitial lung disease in systemic sclerosis: lessons from SLS and FASTNihal Fathi, Daniel E Furst, Philip J ClementsInternational Journal of Epidemiology|June 1, 1997
The impact of immunization control activities on measles outbreaks in middle and low income countriesR B Aylward, J Clements, J M OlivéAgents and Actions. Supplements|January 1, 1992
A re-evaluation of the tissue-specific pattern of expression of the rat kallikrein gene familyJ Clements, A Mukhtar, A Ehrlich, et al.The Bone & Joint Journal|March 30, 2013
Synovial fluid white cell and differential count in the diagnosis or exclusion of prosthetic joint infectionA Dinneen, A Guyot, J Clements, et al.Pharmacological Research|June 1, 1997
Kallikreins and kinins in inflammatory-like events in the reproductive tractJ Clements, A Mukhtar, S Yan, et al.Pageof 39